Featured Research

from universities, journals, and other organizations

Lovastatin: a new weapon against plague?

Date:
June 4, 2010
Source:
CNRS (Délégation Paris Michel-Ange)
Summary:
An experimental study has revealed that lovastatin, a drug prescribed for the treatment of hypercholesterolemia, protects animals against the deadly effects of plague. This infectious disease is on the upsurge in parts of the world. These results obtained by scientists at the Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (CNRS/Université Aix-Marseille 2) have been published in the journal PLoS ONE.

Colonies of Yersinia pestis after culture on CIN agar.
Credit: Copyright URMITE / CNRS

An experimental study has revealed that lovastatin, a drug prescribed for the treatment of hypercholesterolemia, protects animals against the deadly effects of plague. This infectious disease is on the upsurge in parts of the world. These results obtained by scientists at the Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (CNRS/Université Aix-Marseille 2) have been published in the journal PLoS One.

Related Articles


Statins are a class of medicinal products administered to reduce cholesterol levels in people at risk of suffering heart disease because of their hypercholesterolemia. Of the six statin compounds available, lovastatin was the first to be introduced onto the market. Although studies have already demonstrated that this drug can prevent the mortality and morbidity associated with severe infections, no results concerning the bacterium that causes fatal plague, called Yersinia pestis, had been available until now.

After inoculating small rodents with the Yersinia pestis bacterium, the team led by Didier Raoult and Michel Drancourt at the URMITE (CNRS/Université Aix-Marseille 2) showed that animals treated with lovastatin presented fewer and less severe infections. Lovastatin therefore has preventive properties against plague mortality in an animal model. This experimental study also reveals that this statin has no direct antibiotic effect against Yersinia pestis but that it prevents the development of septicemia.

These findings suggest that people receiving statin-based treatment to reduce their cholesterol levels may be protected against the deadly effects of plague. The cause of severe epidemics over the last two thousand years, plague is now considered as a resurgent disease throughout the world. Nearly 50% of cases worldwide are reported in Madagascar, but plague is present in Africa (Democratic Republic of Congo, Malawi and Tanzania), Asia (Vietnam) and America, while a few very limited outbreaks have been observed in Europe on the shores of the Caspian Sea.


Story Source:

The above story is based on materials provided by CNRS (Délégation Paris Michel-Ange). Note: Materials may be edited for content and length.


Journal Reference:

  1. Ayyadurai et al. Lovastatin Protects against Experimental Plague in Mice. PLoS ONE, 2010; 5 (6): e10928 DOI: 10.1371/journal.pone.0010928

Cite This Page:

CNRS (Délégation Paris Michel-Ange). "Lovastatin: a new weapon against plague?." ScienceDaily. ScienceDaily, 4 June 2010. <www.sciencedaily.com/releases/2010/06/100604073638.htm>.
CNRS (Délégation Paris Michel-Ange). (2010, June 4). Lovastatin: a new weapon against plague?. ScienceDaily. Retrieved November 25, 2014 from www.sciencedaily.com/releases/2010/06/100604073638.htm
CNRS (Délégation Paris Michel-Ange). "Lovastatin: a new weapon against plague?." ScienceDaily. www.sciencedaily.com/releases/2010/06/100604073638.htm (accessed November 25, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, November 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com
Madagascar Working to Contain Plague Outbreak

Madagascar Working to Contain Plague Outbreak

AFP (Nov. 24, 2014) — Madagascar said Monday it is trying to contain an outbreak of plague -- similar to the Black Death that swept Medieval Europe -- that has killed 40 people and is spreading to the capital Antananarivo. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Are Female Bosses More Likely To Be Depressed?

Are Female Bosses More Likely To Be Depressed?

Newsy (Nov. 24, 2014) — A new study links greater authority with increased depressive symptoms among women in the workplace. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins